Review began 06/01/2022 review ended 06/09/2022 published 06/13/2022 © copyright

HIGHLIGHTS

• who: Report et al. from the Internal Medicine, Rutgers Health/Monmouth Medical Center, Long Branch, USA have published the research work: Review began 06/01/2022 Review ended 06/09/2022 Published 06/13/2022 u00a9 Copyright, in the Journal: (JOURNAL) of June/13,/2022
• what: Indefinite anticoagulation therapy, rather than three months, is recommended for patients with recurrent DVT or symptomatic PE without identifiable risk factors (unproved VTE) and with low bleeding risk.
• future: Research is needed to assess the value of including quality of life as a routine measure of outcome . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.